Anti inflammatory diet can be as good as the diet you’re following
The latest evidence on the anti inflammatory diet (API) is now out, and it may be better than the diet that you’re currently following.
The new evidence from the Cochrane Collaboration suggests that anti-inflammatory diets may be as effective as the ones you currently follow.
The new Cochrane review published in The Lancet Diabetes & Endocrinology this week suggests that people who follow an API diet can reduce their risk of type 2 diabetes by as much as 45 per cent, and their risk for heart disease by about 45 per,cent.
There are two major limitations to the new evidence, according to Dr Andrew Weyland from the Australian Institute of Health and Welfare’s Institute of Nutrition, Exercise and Sport.
The first is that it only looks at evidence from controlled clinical trials.
So while it is an encouraging study, it is only a pilot study that only examined the effectiveness of an API dietary intervention, so it’s not a reliable measure of effectiveness.
This is also true of other evidence that the diet is effective in reducing cardiovascular risk.
There is some evidence that it can reduce the risk of dying from heart disease in people who are already obese, but there is not a whole lot of evidence to suggest that it is the diet itself that is the real driver of this.
The second limitation to the study is that, like the Cochran’s study, the study only looked at the effect of a single intervention.
It’s possible that the effects of API diets on cardiovascular disease risk might differ between people who have previously been overweight and those who have not.
The authors of the new Cochran study, Dr Paul B. Smith and Dr David A. Miller, found that a single, low-fat, high-protein, low calorie diet was more effective than an API.
The diet they recommended was high in vegetables and fruit, and low in salt, sugar and refined grains.
The researchers used the Food and Drug Administration (FDA) definition of a low calorie, high protein, low fat diet to calculate their results.
They also used the Nutritionist’s Index (NII), which measures how many calories a food provides compared with your total daily energy requirements.
The study found that the API diet reduced cardiovascular risk by 43 per cent in participants who were already overweight, compared with a low-calorie diet which lowered the risk by 35 per cent.
The results were similar for men and women.
Women were significantly less likely to be overweight than men, with an API compared to a low fat, high carbohydrate diet reducing their risk by 33 per cent and a low sugar, high fat diet lowering their risk slightly by 29 per cent when comparing the API with the low-carbohydrate diet.
The findings are significant because they suggest that the anti-inflammation diet is a potentially useful intervention that can reduce both cardiovascular and diabetes risk.
The research was based on data from a cohort of 6,845 men and 6,534 women, and was published in the Journal of the American Medical Association.
The researchers found that while participants who followed an API did not experience a reduction in their overall cardiovascular risk, they had a decrease in their risk in the form of a higher risk of developing type 2 diabetic complications, compared to those who did not follow an algorithm.
The investigators also found that those who followed a low carbohydrate diet, which is the most popular API diet, reduced their risk significantly more than those who ate a high carbohydrate, high sugar diet, with a lower risk of diabetes.
This suggests that the APIs could be more effective in lowering the risk than many other low-cost diets, such as the Atkins diet.
The low-carbon diet has been shown to reduce the rate of heart disease and the risk for developing type 1 diabetes.
The API is popular with people in Australia, who spend up to $20 billion a year on food and beverages, according the Australian Beverage Association.
It is a popular diet with older people, as well as some of the lowest-income people in the country.
In its submission to the trial, the ABA argued that the low cost of API is a major factor in the success of the diet.”API diets are the lowest cost and most effective alternative for reducing the risks of type 1 and type 2 obesity and type 3 diabetes,” it said.
“We welcome the study’s ability to show the potential of an alternative low-glycemic index (LGI) diet as a more effective way to reduce cardiovascular risk.”
This new Cochron study comes after the Australian Research Council (ARC) and the Australian Government funded a trial to determine the effectiveness and safety of an LGI diet for preventing type 2 Diabetes.
In a paper published earlier this year, the ARC suggested that a low glycemic index diet was as effective at lowering the risks associated with Type 2 Diabetes as an API Diet, and could even be more cost effective than a low carb diet.
In the ARC’s paper, the authors suggest that a L